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1. Introduction 
The development of flow cytometric bead-based technology has afforded new perspectives 
in basic and clinical investigation, allowing for the simultaneous measurement of multiple 
analytes in biological samples. In this chapter, we will analyze this innovative technology 
based upon the use of small fluorescent particles coated with highly specific antibodies. 
When performing an immunoassay, a specific antibody is used to identify and quantify the 
concentration of target molecules or analytes in complex samples, such as serum or urine. 
The use of monoclonal antibodies, highly specific, was a great improvement in these assays. 
Currently, the combination of these specific antibodies with different fluorophores and 
novel detection technologies has allowed the achievement of higher sensitivity and several 
improvements in this technique.  
This review will be focused on the multiplexed bead immunoassay (MBIA), which has 
emerged as a powerful tool to simultaneously quantify several analytes in limited sample 
volumes. This is of great interest in Pediatrics, given the difficulty to obtain biological 
samples, particularly in newborns and the clinical interest of this specific type of analysis 
has increased in recent years (Lee et al., 2008). In fact, MBIA presents several advantages 
over the classically used immunoassays in pediatric samples, showing better reliability and 
consistency in the measurements, what is of great interest in longitudinal studies and 
clinical trials (Bomert et al., 2011). 
This multi-analyte analysis method is a solid-phase immunoassay sandwich that uses a 
capture monoclonal antibody for every molecule aimed to study, that are joined to a specific 
microsphere with unique features. This microsphere combines two fluorescent compounds 
that allow for the discrimination from other particles in the assay. A second antibody 
recognizes another epitope, and detects each analyte bound to the complex, by using several 
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detection methods, such as secondary or tertiary antibodies with fluorescent probes or the 
use of phycoerytrin-streptavidin, among others (Chandra et al., 2011). A flow cytometer, 
based in X-map technology, recognizes and integrates the emission of the last signal 
discriminating it according to the specific emission of each microsphere (Vignali et al., 2000). 
Currently, the color-coded microspheres allow the simultaneous performance of up to 100 
determinations. 
However, the development of assays focused on the diagnosis in pediatric disorders is still 
sparse, with new antibody detection panels needed, especially in growth and pubertal 
disorders. The acceptance of MBIA depends on the acquisition of comparable results to 
those achieved by using classical techniques, such as radioimmunoanalysis (RIA) or 
enzyme-linked immunosorbent assay (ELISA), accepted as “gold standards” to date. 
Although some studies have comparatively quantified the measurement of some hormones 
by using classical inmunoassays and MBIA (Liu et al., 2006), further comparisons are 
needed, especially for analytes present at low concentrations, that show significant 
differences in their values according to the methodology used. Therefore, the establishment 
of reference values for the pediatric population and the improvement in the detection of 
those parameters present in a low concentration in samples constitute new challenges for 
both, the investigators and the MBIA manufacturers.  
2. Multiplexed bead immunoassays: principles and technology development 
The limited sample volume and time-saving gains of the MBIA have made it an election 
technique for studies involving multiple factors, such as cytokines and pituitary hormones, 
among others (Djoba-Siawaya et al., 2008). In fact, these complex profiles require an arduous 
procedure and high volume samples when numerous analytes were analyzed by classical 
methods. Nevertheless, this laborious process has been improved by the introduction of 
fluorescent bead assays. 
2.1 General considerations 
The analytes measured by the immunoassays are extensive, including proteins and low 
molecular weight molecules, and have been widely utilized in the diagnosis for over forty 
years (Tetin & Stroupe, 2004). Immunoassays were applied initially to the determination of 
hormones and the antibodies used were polyclonal (Yalow & Berson, 1959). Its routine use 
led to a revolution in the field of endocrinology, as well as to the introduction of new tests 
for the diagnosis and management of endocrine disorders. Subsequently, the use of this 
technique was extended to other areas, such as biochemical disorders and oncology, by the 
determination of enzymes, vitamins and tumor markers. 
Nevertheless, these classical assays show several limitations. Probably the most important, 
is that they only measure the levels of one analyte as a time. Proteins are a part of a complex 
system and clinical diagnosis requires the determination of multiple factors to interpret the 
pathophysiology of a single health problem. Thus, these requirements increase the cost, due 
to the number of assays, with the subsequent economic pressures for the Health Systems. In 
addition, the time spend in their performance is increased and this must be optimized in a 
diagnostic setting. Besides, the determination of several analytes included into an endocrine 
system may lead to different error degrees in each individual determination that may avoid 
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a desirable interpretation of the illness. In addition, there is a minimal risk of radiation and 
the problems of stability of radioisotopes may interfere in the quality of radioimmunoassay. 
All these concerns have been minimized in the past decades. As previously reported, one of 
the greatest advances has been the use of monoclonal antibodies, which represents a 
continuous source of identical molecules with high affinity and specificity (Hoogenboom, 
2005). Also, the development of software for data processing and the incorporation of non-
isotopic reporters, such as enzymes that generate chromogenic, fluorescent and 
chemiluminescent products have improved these classical assays. The development of 
amplification methods (Figure 1) together with the use of above mentioned products has 
improved the sensitivity of these assays, allowing for the progressive use of smaller sample 
size, making it possible their application to pediatric samples (Barrios et al., 2007). 
2.2 Basic principles 
The discovery of new fluorescent compounds has improved the sensitivity of classical 
immunoassays. In recent years, protein microarrays have emerged as a powerful tool to 
provide quantitative data of proteins in biological samples. In traditional protein 
microarrays, capture reagents are immobilized in defined locations and in the presence of 
substrates, microspots are generated. After that, the deconvolution of the multiplexed 
measurements, allows for the identification and quantification of the set of selected proteins 
(Mirzabekov & Kolchinsky, 2002). 
A key advance in multiplexed measurements has been the spatial segregation of the 
mentioned immobilized protein, encoded beads yield so-called MBIA. Multiplexed bead 
immunoassay kits contain microspheres, that are highly uniform with the same size (around 
3-6 μm, depending of the manufacturer) and are polystyrene beads cross-linked during 
polymerization for physical and thermal stability. These microspheres are grouped into sets; 
each one is subsequently embedded with specific quantities of red and orange fluorescent 
dyes. The different proportion of these dyes gives each specific set of microspheres a unique 
spectral signature. Each specific set of microspheres is used as the solid support for the 
conjugation with a distinct reactant for each particular analyte. Among the reactants, there 
are enzyme substrates, antigens, receptors and antibodies. 
In the MBIA, the capture antibody of each immunosorbent assay is coupled to one of 100 
different microsphere bead sets, a 10 x 10 matrix with capacity and the combination of red 
and orange florescent dyes. After the capture of the analyte, the complexes are washed 
applying vacuum separation. The vacuum is applied to a 96-well plate, in order to separate 
the liquid, whereas the microspheres are retained in the filter. Afterwards, the addition of a 
solution with a second biotinylated antibody followed by resuspension allows for the 
creation of a “sandwich”. After a new washing, a complex of streptavidin conjugated to 
phycoerythrin is added. The amount of the analyte binded to the beads is then quantified 
through the use of phycoerythrin, a green-fluorochrome reported dye, excited by the array 
reader at a wavelength of 532 nm, whereas the emission is detected around 575 nm (Figure 
2). Thus, in each immunosorbent assay, the intensity of this green fluorochrome measured 
by the reader is directly proportional to the amount of analyte bound to the surface of each 
microsphere (Thrailkill et al., 2005; Van der Heyde & Gramaglia, 2011). 
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A, fluorescent bound detection antibodies. B, fluorescent labeled compounds-tertiary antibodies. C, 
biotinylated detection antibodies with streptavidin-phycoerythrin conjugate. D, streptavidin-phycoerythrin 
conjugate staining amplified with biotinylated anti-streptavidin-phycoerythrin antibodies. E, streptavidin-
linked horseradish peroxisade linked to a species-specific tertiary antibody activates chemiluminiscent 
substrates or generates different flourophores. F, resonance light-scattering colloid gold particles coated 
with an antibiotin antibody. Modified from Nielsen & Geierstanger. J Immunol Methods 2004; 290: 107-120. 
Fig. 1. Signal generation and amplification methods.  
 
The capture monoclonal antibody is coupled to the bead (microsphere). After binding of the analyte a 
second biotinylated antibody is added. After addition of a streptavidin-phycoerythrin conjugate, dyes 
embedded in the beads and phycoerythrin are excited (wavy lines) and both compounds give two types 
of light emission. Modified from Barrios et al., Rev Esp Pediatr 2007; 63: 157-161. 
Fig. 2. Schematic representation of an isolated reaction of a MBIA with the reagents used in 
this technique.  
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There are two lasers in the adapter array reader for MBIA, the first laser classifies each 
microsphere and its bound analyte and the second quantifies the amount of analyte bound 
to each microsphere. The first laser, known as red laser, excites the dyes of each microsphere 
and the fluorescent signal of each microsphere is separated with selective filters and 
converted in intensity units by the combination of fluorescent detectors and a digital 
processor, being the microsphere arranged. The second laser, named green laser, stimulates 
the fluorochromes bound to the analytes (in our case, phycoerythrin) and the signal is 
distinguished with emission filters and translated to intensity units by specific detectors and 
a signal processor, and the amount of analyte is measured. This data are acquired by 
different adapted flow cytometers attached to computers with special software (Figure 3).  
 
Fig. 3. Suspension array system with high throughout put fluidics system. 
This special cytometer is a dual-laser, flow-based microplate reader system. The content of 
each well is drawn up into the reader. The laser and associated optics detect the fluorescence 
of the individual beads and the fluorescence signal on the bead surface. This identifies each 
assay and reports the levels of target protein in the well. The detected intensity of 
fluorescence on the beads indicates the quantity of analytes. Thus, the system calculates the 
green fluorescence and the combination of red and orange fluorescence of each microsphere 
by using three detectors. The software separates the pool of microspheres using the orange 
and red fluorescence data and integrates these data with the average amount of green 
fluorescence for each bead set (Figure 4). A high-speed digital processor manages the data 
output, analyzed as fluorescence intensity on the software. 
2.3 Assay guidelines and technical considerations 
One of the main focuses of this review is to analyze the assay procedure in order to obtain 
reliable results with this technique. The current literature contains many examples of user 
and manufacturer product evaluations; however, some recommendations that will improve 
the performance of MBIA must be taken into account. 
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Each set of microbeads is quantitated in the histogram (A) and separated by the Luminex© system in a 
two-dimensional bead map (B), permitting the simultaneous quantitation of different analytes in the 
same sample. Results are given as fluorescence mean intensity (C) and the concentration of the analyte 
in the problem sample is obtained by extrapolation from a standard curve (D). 
Fig. 4. Separation and quantification of the analyte concentrations by the suspension array 
reader system.  
As the microspheres have different fluorescent dyes that are light sensitive, we must protect 
the beads from direct light by covering the tubes with aluminium foil. Sometimes, this 
procedure is not necessary, because the manufacturer provides the MBIA kits with dark 
tubes, thus avoiding light exposition. We also must keep the microspheres at 4ºC, avoiding 
freezing. 
Another problem is the eventual aggregation of the microspheres. Sonication during 15-60 
seconds keeping the tubes on ice is a procedure to separate aggregated microspheres, but it 
may cause hurt in the microsphere suspension. We usually used gentle vortexing during 5-
10 minutes to obtain a homogeneous mixture. Thus, we may avoid not only a potential 
harmful effect on the sample, but also the possible loss of a part of the liquid phase during 
sonication. Another common alternative process is the use of a bath sonicator, by placing the 
probe sonicator tip in a bath of water and inserting the tube with microspheres near the tip, 
avoiding touching it. 
Multiplexed bead immunoassays require washing during the assay period to separate the 
analyte of second antibody bound to the microsphere surface from the unbound reactants. 
The most common procedure is the vacuum separation. The reactions are performed in 
microtiter filter-bottom 96-well plates and vacuum is applied to the plate allowing the liquid 
to filter through while retaining the microbeads on the filter (Figure 5A). A new procedure 
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is the use of magnetic microbeads and conventional 96 well plates. In this situation, a 
microplate washer with a magnetic platform is used to separate these microspheres of 
unbound fraction (Figure 5B).  
 
A, vacuum manifold system. The microtiter filter-bottom 96-plate is on a support and vacuum is 
applied with a conventional pump. Liquid is collected into a manifold. B, Microplate washer with 
magnetic platform. Conventional ELISA 96-plate and magnetic microbeads are used to separate liquid 
of microbeads. 
Fig. 5. Separation of microbeads and liquid containing unbound fraction. 
We may also develop new MBIAs, coupling the capture antibodies to the microspheres. First, 
we must choose a set of microbeads with significant diverse proportion of dyes fluorescence 
compounds (red and orange) in order to maintain sufficiently separated the reading areas 
obtained in the two-dimensional diagram by the suspension array reader system (see figure 
5B). In this way, we will avoid potential overlapping among different bead readings. 
Microspheres with fluorescent dyes are supplied at standard concentrations, but during the 
coupling process may diminish due to loss during washing. This loss is not uniform and it 
may change for multiple causes, such as pressure of vacuum manifold, and reactant 
employed in coupling, among others (Bio-Plex Manager Software, User Guide). It is difficult 
the optimization of the assay because we must take into consideration the different 
proportions of reactants (antibodies, analytes, fluorophore conjugates, assay buffers, etc.), 
temperatures and times of incubation and perhaps the most critical variable, the total 
surface area (total number of microbeads). To obtain reliable results, it is necessary to know 
the number of microspheres by counting them in a hemocytometer. These are also crucial 
aspects in the new MBIA using small quantity of sample, the microfluidic bead-based 
immunoassay that it was be developed to perform a multiplexed assay in a capillary, 
requiring only 1 µl assay volume (Yu et al., 2010). 
Monoclonal capture antibodies must be bound to a specific each set of microspheres. There 
are some kits to perform this procedure; however is difficult to establish not only the 
adequate number of beads and concentration of the capture antibody, but also the quantity 
of secondary antibody to obtain a good assay performance (Djoba-Siawaya et al., 2008). 
Assay performance of new developed MBIAs must be compared with classical methods, 
such as radioimmunoassay o ultra-sensitive enzyme-linked immunosorbent assay, 
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considered as “gold standards” in the laboratory (Krouwer et al., 2002; Elshal & McCoy, 
2006). The development of new panels using MBIA requires testing the effect of the 
biological matrix. Serum or plasma specimens are complex samples that are frequently 
diluted before addition in the well. The diluent has to imitate the sample matrix in order to 
obtain the same fluorescent background. There are many commercially available diluents 
and it is also necessary to analyze the effect of dilution and its addition to interpolate 
unknown concentrations (Pfleger et al., 2008). 
Another aspect is the optimization of the parameters of the acquisition of data and analysis 
of results in the reader, by using the associated software. We must start by adjusting the 
needle according the manual instructions. The height of the array reader sample needle 
must be adjusted when the style of microtiter plate has been modified, to optimize the 
sample acquisition. The next step is the calibration of the array reader, necessary for optimal 
performance and reproducibility of results (Bio-Plex Manager Software, User Guide). 
Commercial manufacturers provide some kits containing calibration microspheres with 
stable fluorescent intensities in the emission wavelength ranges of the classification 
channels. The calibration process employs these microbeads to regulate voltage settings for 
optimal microsphere classification and reporter readings over time. 
After preparation of the protocol, we need to define additional characteristics, as the 
number of bead counts, sample size and bead map selection to obtain an adequate 
histogram and bead map (Figures 4A & 4B). These graphs are updated during the reading 
(Figure 4C). Results are extrapolated from each standard curve for each analyte (Figure 4D). 
At the end of the reading process, the software generates a results file, containing the data, 
protocol parameters used and analysis tools for interpreting the data. Thus, we can 
reanalyze raw data by testing the effect of dilution or the regression method used. We are 
also able to change the double discriminator gate range and to recalculate the data based in 
the new range. During the reading, this discriminator of the array reader determines the 
amount of light scatter of the beads detected by the red laser. Particle size is proportional to 
light scatter and an internal discriminator gate identifies particles smaller o larger than 
single microbeads, including aggregates that may interfere in the results. 
In addition to these studies, development of a new MBIA or the inclusion of a new analyte 
to a pre-existent multiplexed panel also requires the analysis of classical assay 
characteristics, as sensitivity, specificity, precision, recovery and linearity, among others 
(Krouwer et al., 2002; Liu et al., 2005; Dossus et al., 2008; Martos-Moreno et al., 2010). 
3. Interest of MBIA in pediatrics 
The study of growth hormone axis, pituitary hormone panel or cytokine expression profiling, 
among other examples, have become as established guidelines for the identification and 
characterization of several diseases. However, the determination of multiple parameters by 
classical immunoassays is a laborious process requiring a big amount sample volume, a 
problematic aspect for patients, especially when these subjects are newborns or children. 
Multiplexed immunoassays based on protein microarray platforms have been used in the 
detection and confirmation of biomarkers associated with several diseases (Hsu et al., 2008; 
Sauer et al., 2008; Paczesny et al., 2009). Nevertheless, most of these studies have been 
www.intechopen.com
 
Multiplexed Bead Immunoassays: Advantages and Limitations in Pediatrics 
 
173 
performed in adults and it is necessary to carry out these determinations in children. Among 
studies in children, most of them have been conducted to analyze serum cytokine profiling 
(Pranzatelli et al., 2011). In addition, most of the parameters determined in boys and girls 
during pubertal development show variations in their concentrations, due to 
anthropometric and biochemical changes influencing some of these variables. Thus, MBIA is 
a good method, because it allows for the simultaneous determination of multiple 
parameters in a single assay, avoiding inter-assay variations. This property offers reliable 
data and could help in the diagnosis and or follow up of pediatric patients. Thus, different 
studies, clinical trials or monitoring of pediatric patients during disease treatment require 
the determination of multiple parameters during extended periods of time (Martos-Moreno 
et al., 2011a). As an example, in the Table 1, we show the effect of weight loss on several 
adipokines in obese children after dietary intervention. 
This technique also facilitates in obtaining a “pool” of reference values during childhood 
and puberty and may improve the knowledge of the physiology of any given endocrine 
axis. As it is mentioned above, the determination of several analytes at the same time, avoid 
the variability among them and allows a better interpretation of the physiology of the 
studied axis. In addition, the obtaining of reference data in children involves the recruitment 
of boys and girls in different Tanner stages, due to the effect of sex and biochemical changes 
through pubertal development. MBIA could be a choice method, as not only integrates all 
parameters in one determination, but also allows analyzing longitudinal changes in all of 
them. Here we show reference data of different adipokines in boys and girls through 
childhood and adolescence (Table 2).  
 
Group Adiponectin Leptin Resistin TNF-ǂ IL-6 
Control 15.8 ± 6.3 4.3 ± 3.1 13.8 ± 6.2 4.6 ± 2.2 2.2 ± 2.0 
Obese B 16.3 ± 7.4 36.9 ± 13.6** 14.7 ± 6.5 6.1 ± 2.0 2.5 ± 2.0 
Obese -1 19.1 ± 7.2 16.4 ± 13.3**## 12.2 ± 5.5 5.4 ± 3.2 2.1 ± 1.5 
Obese -2 25.7 ± 11.4*# 16.1 ± 11.3**## 15.7 ± 8.4 4.8 ± 2.4 2.0 ± 1.3 
Adiponectin, leptin, resistin, tumoral necrosis factor-ǂ (TNF-ǂ) and interleukin-6 (IL-6) levels were 
measured by MBIA in healthy children (control) and prupubertal obese subjects at baseline (Obese B) 
and after reduction of their body mass index by 1 SDS (Obese -1) and 2 SDS (Obese -2). Data expressed 
as mean ± standard deviation. *p<0.01, **p<0.001 vs. control; #p<0.01, ##p<0.001 vs. obese B. Modified 
from Martos-Moreno et al. Clin Chem Lab Med 2010; 48: 1439-1446. 
Table 1. Serum concentrations of adipokines in control and obese children 
Another aspect of special interest in Pediatrics is the sensitivity of the MBIAs. Serum 
samples of children and newborns have low levels of some analytes and sensitivity is crucial 
to determine them. The fluorescent readout if MBIA is more sensitive than the colorimetric 
signal of ELISA, where it is required a step of enzyme amplification. Moreover, the 
sensitivity can be augmented by reducing the number of bead in each assay, increasing in 
this manner the ratio of analyte to capture antibody without reducing the number of capture 
antibodies per bead. In addition, MBIA may be more reproducible than ELISA. Thus, the 
replicates usually show little variation in fluorescence, whereas ELISA significant variations 
between experiments and between plates within assays (Leng et al., 2008). Multiplexed bead 
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assays are more accurate because the data are calculated from the mean of 50-100 beads, 
each of which functions as an individual replicate. This is an additional advantage in 
longitudinal studies, very frequents in pediatric population. 
The MBIAs may be adapted to carry out immunoassays for identifying antibodies. It is 
necessary to introduce variations in the assay design (Morgan et al., 2004). Here, purified 
antigens are conjugated to the beads and incubated with any sample of interest, followed 
with species-specific anti-immunoglobulin reagent, labelled with a fluorochrome. The mean 
fluorescence intensity is directly proportional to the amount of antibody bound to the 
antigen on the bead. These adapted assays have been employed to detect antibodies in 
diagnosis of celiac disease (Yiannaki et al., 2004), autoimmune thyroid disease (Tozzoli et al., 
2006) and meningitis (Shoma et al., 2011) during childhood. 
Multiplex applications are not restricted to the detection of proteins and antibodies, as this 
technique has also been used during a decade for the simultaneous detection of different 
DNA sequences. Among the specific applications include genotyping of single nucleotide 
polymorphisms, screening of genetic diseases, genotyping of the major histocompatibility 
complex and molecular analysis of infectious organisms (Ye et al.., 2001; Cesbron-Gautier et 
al., 2004; Dunbar et al., 2003). The main use of MBIA in this field has been the detection of 
mutations associated with disease; so, one of the first applications of genotyping was the 
analysis of multiple variants of ǃ-globin in capillary blood of neonates (Colinas et al., 2000). 
Also this technology has been used for genotyping in samples from patients with a 
predisposition to thrombophilia (Musher et al., 2002) and detection of fusion transcripts of 
chromosomal translocations in children with acute lymphoblastic leukemia (Wallace et al., 
2003). 
 
Tanner stage Adiponectin Leptin Resistin TNF-ǂ IL-6 
I      
Female 15.6 ± 4.2 4.8 ± 3.6 13.5 ± 5.0 4.2 ± 1.6 2.6 ± 2.2 
Male 16.2 ± 5.6 3.9 ± 2.7 12.6 ± 6.3 4.2 ± 2.0 1.9 ± 1.8 
II      
Female 16.7 ± 12.2 5.7 ± 2.7 15.9 ± 4.3 4.0 ± 1.6 2.6 ± 2.2 
Male 17.0 ± 5.0 4.1 ± 2.8 16.9 ± 7.1 4.0 ± 1.3 2.4 ± 1.8 
III + IV      
Female 18.0 ± 6.2 11.4 ± 4.2 16.5 ± 3.8 4.6 ± 1.7 1.3 ± 0.4 
Male 13.4 ± 6.8 6.4 ± 2.7 16.8 ± 7.0 4.4 ± 1.3 1.5 ± 0.6 
V      
Female 12.1 ± 4.9 12.1 ± 4.3 29.4 ± 8.9 4.9 ± 1.1 1.5 ± 1.2 
Male 18.3 ± 5.2 6.2 ± 3.1 22.8 ± 8.5 4.6 ± 1.6 1.0 ± 0.5 
Adiponectin, leptin, resistin, tumoral necrosis factor-ǂ (TNF-ǂ) and interleukin-6 (IL-6) levels were 
measured by MBIA in healthy girls and boys in the different pubertal stages (Tanner stage). Data 
expressed as mean ± standard deviation. Modified from Martos-Moreno et al. An Pediatr (Barc.) 2011b; 
74: 356-362. 
Table 2. Reference values of adipokines in children throughout development 
www.intechopen.com
 




In spite of the advantages of this technology, it is important to keep in mind the scarce 
development of assays in the field of pediatric disorders. Therefore, the development of new 
multiplexed panels is needed, especially in those pediatric pathologies related to 
endocrinology of growth and pubertal disorders. 
Special attention should be paid when reporting absolute values with MBIA. The 
acceptance of this technique depends on the acquisition of comparable results to those 
achieved by using classical techniques, accepted as the “gold standards” in the laboratory. 
To date, we and others have compared these methodologies for some hormones (Martos-
Moreno et al., 2010; Liu et al., 2005), but further comparisons are needed, especially for 
analytes that are present at very low concentrations in pediatric samples, since the 
concentrations obtained with MBIA and classical ultra-sensitive immunoassays are 
distinct for some analytes and also show that the differences between the methods are 
composed of both constant and proportional components, preventing a direct 
comparability between both assays. 
A limitation in some MBIAs is the interpretation and reporting of analyte values at 
extremely low concentrations. One of the possible advantages of this assay is that the 
dynamic range seems to be much broader than classical ELISAs. However, many sensitivity 
issues in the very low range of concentrations remain unresolved (Liu et al., 2005; Leng et 
al., 2008), especially for several cytokines.  
Therefore, the establishment of reference values for the pediatric population and the 
improvement in the detection of determined parameters that are present at low levels in 
serum is a challenge for the investigators and the MBIA manufacturers, respectively.  
5. Future research 
These methods have an excellent accuracy and reliability, together with an excellent 
sensitivity for most analytes. However, some analytes are currently determined by ultra-
sensitive immunoassays. A challenge of this technology is to improve the sensitivity of some 
analytes present at very low concentrations in biological fluids, as well as in tissues, in order 
to its applicability in new areas of routine diagnosis.  
Another important aspect is the improvement of specificity for some parameters, which is 
essentially limited by the quality of antibodies employed in the MBIA (Vignali, 2000). Thus, 
the use of some monoclonal antibodies in classical immunoassays, such as 
enzimoimmunoassay or radioimmunoassay, does not affect in a significant manner the 
results, but it may be a big issue for MBIA. The near future will show whether MBIA exhibit 
a greater applicability in diagnostics in Pediatrics.  
Another objective is the development of commercial kits that allow the simultaneous 
analysis of factors that require extractive procedures or alternative processes for assessment, 
such as growth factors, together with other molecules in which it is not necessary this 
preliminary stage. It is also required the improvement of MBIAs to evaluate the molecular 
heterogeneity of certain hormones that have several isoforms (Popii & Baumann, 2004). In 
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this sense, the development of immunology allows characterizing new monoclonal 
antibodies against different epitopes, solving some problems of inadequate sensitivity or 
cross-reactivity with classical antibodies (Feldhaus et al., 2003). 
These assays will improve the throughput by greatly enhancing the quantity of information 
achieved from a single experiment. Moreover, the development of new microfluidic bead-
based immunoassays will allow diminishing the expenditures of reagents and reducing the 
requirements of biological sample, very important in pediatric patients. Based upon their 
capabilities, MBIA will be proposed for use in disease screening and probably will open up 
new possibilities in the follow up of patients during therapy. 
6. Conclusion 
Multiplexed bead immunoassays could result more cost-effective for the measurements of 
selected analytes, diminishing inter-assay variations and reducing the volume of sample 
needed, what would be particularly interesting in Pediatrics, especially when limited 
amounts of samples are available, which is usually the case of young children. The current 
advantages in time, ability to simultaneously measure analyte concentrations in the same 
conditions and high performance of multiplex analysis will allow MBIA to be a more useful 
tool in evaluating the pediatric diseases. 
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